AAAAAA
Results: 1-25/32
Authors:
Stewart, S
Blue, L
Capewell, S
Horowitz, JD
McMurray, JJ
Citation: S. Stewart et al., Poles apart, but are they the same? A comparative study of Australian and Scottish patients with chronic heart failure, EUR J HE FA, 3(2), 2001, pp. 249-255
Authors:
Friedell, ML
Joseph, BP
Cohen, MJ
Horowitz, JD
Citation: Ml. Friedell et al., Surgery for carotid artery stenosis following neck irradiation, ANN VASC S, 15(1), 2001, pp. 13-18
Authors:
Chirkov, YY
Holmes, AS
Willoughby, SR
Stewart, S
Wuttke, RD
Sage, PR
Horowitz, JD
Citation: Yy. Chirkov et al., Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets, J AM COL C, 37(7), 2001, pp. 1851-1857
Authors:
Cleland, JGF
Thygesen, K
Uretsky, BF
Armstrong, P
Horowitz, JD
Massie, B
Packer, M
Poole-Wilson, PA
Ryden, L
Citation: Jgf. Cleland et al., Cardiovascular critical event pathways for the progression of heart failure - A report from the ATLAS study, EUR HEART J, 22(17), 2001, pp. 1601-1612
Authors:
Ellis, GR
Anderson, RA
Chirkov, YY
Morris-Thurgood, J
Jackson, SK
Lewis, MJ
Horowitz, JD
Frenneaux, MP
Citation: Gr. Ellis et al., Acute effects of vitamin c on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure, J CARDIO PH, 37(5), 2001, pp. 564-570
Authors:
Kucia, AM
Taylor, KTN
Horowitz, JD
Citation: Am. Kucia et al., Can a nurse trained in coronary care expedite emergency department management of patients with acute coronary syndromes?, HEART LUNG, 30(3), 2001, pp. 186-190
Authors:
Horowitz, JD
Stewart, S
Citation: Jd. Horowitz et S. Stewart, Heart failure in older people: the epidemic we had to have, MED J AUST, 174(9), 2001, pp. 432-433
Authors:
Massie, BM
Armstrong, PW
Cleland, JGF
Horowitz, JD
Packer, M
Poole-Wilson, PA
Ryden, L
Citation: Bm. Massie et al., Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure - Results from the ATLAS trial, ARCH IN MED, 161(2), 2001, pp. 165-171
Authors:
Beltrame, JF
Turner, SP
Horowitz, JD
Citation: Jf. Beltrame et al., Persistence of the coronary slow flow phenomenon, AM J CARD, 88(8), 2001, pp. 938-938
Authors:
Sculpher, MJ
Poole, L
Cleland, J
Drummond, M
Armstrong, PW
Horowitz, JD
Massie, BM
Poole-Wilson, PA
Ryden, L
Citation: Mj. Sculpher et al., Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study, EUR J HE FA, 2(4), 2000, pp. 447-454
Authors:
Ryden, L
Armstrong, PW
Cleland, JFG
Horowitz, JD
Massie, BM
Packer, M
Poole-Wilson, PA
Citation: L. Ryden et al., Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus - Results from the ATLAS trial, EUR HEART J, 21(23), 2000, pp. 1967-1978
Authors:
Horowitz, JD
Citation: Jd. Horowitz, Home-based intervention: the next step in treatment of chronic heart failure?, EUR HEART J, 21(22), 2000, pp. 1807-1809
Authors:
Kennedy, JA
Kiosoglous, AJ
Murphy, GA
Pelle, MA
Horowitz, JD
Citation: Ja. Kennedy et al., Effect of perhexiline and oxfenicine on myocardial function and metabolismduring low-flow ischemia/reperfusion in the isolated rat heart, J CARDIO PH, 36(6), 2000, pp. 794-801
The positive inotropic effects of milrinone but not of digoxin are attenuated at short cycle lengths
Authors:
Zeitz, CJ
Ritchie, RH
Jarrett, RG
Hii, JTY
Wuttke, RD
Horowitz, JD
Citation: Cj. Zeitz et al., The positive inotropic effects of milrinone but not of digoxin are attenuated at short cycle lengths, J CARDIO PH, 35(3), 2000, pp. 427-433
Authors:
Uretsky, BF
Thygesen, K
Armstrong, PW
Cleland, JG
Horowitz, JD
Massie, BM
Packer, M
Poole-Wilson, PA
Ryden, L
Citation: Bf. Uretsky et al., Acute coronary findings at autopsy in heart failure patients with sudden death - Results from the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial, CIRCULATION, 102(6), 2000, pp. 611-616
Authors:
Sage, PR
de la Lande, IS
Stafford, I
Bennett, CL
Phillipov, G
Stubberfield, J
Horowitz, JD
Citation: Pr. Sage et al., Nitroglycerin tolerance in human vessels - Evidence for impaired nitroglycerin bioconversion, CIRCULATION, 102(23), 2000, pp. 2810-2815
Authors:
Chirkov, YY
Holmes, AS
Chirkova, LP
Horowitz, JD
Citation: Yy. Chirkov et al., Nitrate resistance in platelets from patients with stable angina pectoris - Response, CIRCULATION, 102(11), 2000, pp. E87-E87
Authors:
Kucia, AM
Horowitz, JD
Citation: Am. Kucia et Jd. Horowitz, Is informed consent to clinical trials an "upside selective" process in acute coronary syndromes?, AM HEART J, 140(1), 2000, pp. 94
Authors:
Horowitz, JD
Citation: Jd. Horowitz, Nitrovasodilators, CONTEMP CAR, 2000, pp. 383-409
Authors:
Cleland, JGF
Armstrong, P
Horowitz, JD
Massie, B
Packer, M
Poole-Wilson, PA
Ryden, L
Citation: Jgf. Cleland et al., Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study, EUR J HE FA, 1(1), 1999, pp. 73-79
Authors:
Horowitz, JD
Citation: Jd. Horowitz, Part II: The ATLAS study: low-dose versus high-dose lisinopril in heart failure, INT J CL PR, 1999, pp. 15-16
Authors:
Sage, PR
Kiosoglous, AJ
Wuttke, RD
Horowitz, JD
Citation: Pr. Sage et al., Early treatment with verapamil or diltiazem in patients with acute myocardial infarction: Safety and possible beneficial effects, CARDIO DRUG, 13(4), 1999, pp. 309-313
Authors:
Beltrame, JF
Horowitz, JD
Citation: Jf. Beltrame et Jd. Horowitz, ST elevation secondary to microvascular dysfunction, J AM COL C, 34(1), 1999, pp. 312-313
Authors:
Stewart, S
Marley, JE
Horowitz, JD
Citation: S. Stewart et al., Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study, LANCET, 354(9184), 1999, pp. 1077-1083
Authors:
Tornvall, P
Chirkova, L
Toverud, KD
Horowitz, JD
Chirkov, Y
Citation: P. Tornvall et al., Native and oxidized low density lipoproteins enhance platelet aggregation in whole blood, THROMB RES, 95(4), 1999, pp. 177-183